Medical Director
Lamas Medical Allergy and Immunology
Miami, FL, United States
Diplomate, American Board of Allergy and Immunology
Dr. Ana M. Lamas received her Bachelor of Arts cum laude from Harvard-Radcliffe College. She then received her medical degree from Yale University, School of Medicine graduating with membership to the prestigious honor medical society, Alpha Omega Alpha. While at Yale, she received the Yale International Student Fellowship and the Merck Award. Dr. Lamas completed her internship and residency in Internal Medicine at the Columbia University Medical Center/Presbyterian Hospital in New York City. From there, she completed her fellowship in Allergy and Clinical Immunology at Johns Hopkins University, School of Medicine where she was the recipient of the Young Investigator Award, the President’s Grant-in-Aid Award, First Prize and the Minority Investigator Research Supplement Award. While at Johns Hopkins, Dr. Lamas was involved in Immunology research on the human eosinophil. Her research led to the publication of several scientific articles in peer reviewed journals as well as book chapters in Immunology text books.
After completing her fellowship, Dr. Lamas returned to Miami as an Assistant Professor of Medicine at the University of Miami School of Medicine. While in this position, she was responsible for the inpatient management of internal medicine patients, was the director of the Adult Allergy and Immunology Clinic and had a research laboratory. She also taught medical students, interns and residents in Internal Medicine and Otolaryngology residents in the Allergy Clinic.
In the mid 1990’s, Dr. Lamas joined her father, the late Juan F. Lamas, M.D., in the private practice of Allergy and Clinical Immunology in Miami. Dr. Lamas is Board Certified in Internal Medicine and Board Certified in Allergy and Immunology.
Dr. Lamas is a member of the American Medical Association, the American Academy of Allergy, Asthma and Immunology and of the Florida Allergy, Asthma and Immunology Society.
Evaluation and Treatment of Primary Immunoglobulin Deficiency Disorders in Chronic Rhinosinusitis
Tuesday, October 1, 2024
9:30 AM – 10:30 AM EDT
Disclosure(s):
faculty for this accredited education activity has no relationship(s) with ineligible companies to disclose.